PREPIDIL (dinoprostone) by Pfizer is hormone. First approved in 1992.
Drug data last refreshed 21h ago · AI intelligence enriched 2w ago
PREPIDIL (dinoprostone) is a prostaglandin analog administered as an endocervical gel for cervical ripening in pregnant women. It works by stimulating prostaglandin F2α production, which softens and dilates the cervix and sensitizes the uterus to oxytocin, facilitating labor induction. The drug was approved in 1992 and remains a standard agent in obstetric care.
Product is in late lifecycle with moderate competitive pressure (30%), signaling potential team right-sizing and shift toward legacy/efficiency-focused roles.
hormone. In pregnancy, dinoprostone is secreted continuously by the fetal membranes and placenta and plays an important role in the final events leading to the initiation of labor including cervical ripening. Dinoprostone stimulates the production of prostaglandin F 2α ( PGF 2α), which sensitizes…
Prostaglandin Analog
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
An RCT of a Synthetic Osmotic Cervical Dilator for Induction of Labour in Comparison to Dinoprostone Vaginal insErt
Efficacy of Induction of Labor on Term Using a Double Balloon Catheter Compared to Dinoprostone Vaginal-insert
Efficacy & Safety Study Comparing Misoprostol Vaginal Insert (MVI) Versus Dinoprostone Vaginal Insert (DVI) for Reducing Time to Vaginal Delivery
Open Label Comparative Trial of Dinoprostone Plus or Minus Oxytocin Versus Oxytocin Alone in Cervical Ripening for Labor Induction
Worked on PREPIDIL at Pfizer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Working on PREPIDIL offers stable, specialized experience in obstetric pharmaceuticals but limited growth trajectory as the product approaches loss of exclusivity. Career advancement will depend on pivoting to legacy brand management, generic defense, or adjacent Pfizer portfolios.